Ashland Inc. (ASH)
NYSE: ASH
· Real-Time Price · USD
49.30
-0.74 (-1.48%)
At close: May 23, 2025, 3:59 PM
49.30
0.00%
After-hours: May 23, 2025, 05:32 PM EDT
Ashland Revenue Breakdown
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 |
|---|---|---|---|---|---|---|---|
| Intermediates And Solvents Revenue | 144M | 185M | 815M | 114M | 73M | 111M | 331M |
| Intermediates And Solvents Revenue Growth | -22.16% | -77.30% | +614.91% | +56.16% | -34.23% | -66.47% | n/a |
| Life Sciences Revenue | 810M | 869M | 719M | 229M | 226M | n/a | n/a |
| Life Sciences Revenue Growth | -6.79% | +20.86% | +213.97% | +1.33% | n/a | n/a | n/a |
| Personal Care And Household Revenue | 634M | 598M | n/a | 180M | 185M | n/a | n/a |
| Personal Care And Household Revenue Growth | +6.02% | n/a | n/a | -2.70% | n/a | n/a | n/a |
| Specialty Additives Revenue | 572M | 600M | n/a | 203M | 199M | n/a | n/a |
| Specialty Additives Revenue Growth | -4.67% | n/a | n/a | +2.01% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 1.49B | 1.56B | 1.66B | 637M | 878M | 959M | 1.42B | 2.01B | 2.39B |
| Non-Us Revenue Growth | -4.37% | -6.20% | +160.60% | -27.45% | -8.45% | -32.46% | -29.42% | -15.71% | n/a |
| United States Revenue | 624M | 634M | 731M | n/a | n/a | n/a | n/a | 1.25B | 2.56B |
| United States Revenue Growth | -1.58% | -13.27% | n/a | n/a | n/a | n/a | n/a | -51.27% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 85M | 78M | 105M | 114M | 106M | 83M | 109M | 82M | 79M | 93M | 94M | 127M | 90M | 82M | 85M | 98M | 84M | 101M | 109M | 113M | 103M | 99M | 109M | 150M | 136M | 143M | 234M | 203M | 163M | 171M | 177M | 182M | 245M | 239M | 502M | 160M | 258M | 224M | 383M | 216M | 203M |
| Selling, General, and Administrative Revenue Growth | +8.97% | -25.71% | -7.89% | +7.55% | +27.71% | -23.85% | +32.93% | +3.80% | -15.05% | -1.06% | -25.98% | +41.11% | +9.76% | -3.53% | -13.27% | +16.67% | -16.83% | -7.34% | -3.54% | +9.71% | +4.04% | -9.17% | -27.33% | +10.29% | -4.90% | -38.89% | +15.27% | +24.54% | -4.68% | -3.39% | -2.75% | -25.71% | +2.51% | -52.39% | +213.75% | -37.98% | +15.18% | -41.51% | +77.31% | +6.40% | n/a |
| Research and Development Revenue | 14M | 13M | 13M | 15M | 14M | 12M | 14M | 12M | 12M | 13M | 15M | 14M | 13M | 13M | 13M | 15M | 14M | 15M | 16M | 14M | 18M | 16M | 15M | 17M | 17M | 17M | 21M | 21M | 21M | 21M | 22M | 20M | 24M | 23M | 26M | 22M | 25M | 25M | 36M | 24M | 25M |
| Research and Development Revenue Growth | +7.69% | 0.00% | -13.33% | +7.14% | +16.67% | -14.29% | +16.67% | 0.00% | -7.69% | -13.33% | +7.14% | +7.69% | 0.00% | 0.00% | -13.33% | +7.14% | -6.67% | -6.25% | +14.29% | -22.22% | +12.50% | +6.67% | -11.76% | 0.00% | 0.00% | -19.05% | 0.00% | 0.00% | 0.00% | -4.55% | +10.00% | -16.67% | +4.35% | -11.54% | +18.18% | -12.00% | 0.00% | -30.56% | +50.00% | -4.00% | n/a |